Therapy Areas: Inflammatory Diseases
Moderna Receives Funding Award from CEPI to Accelerate Development of Messenger RNA Vaccine Against Novel Coronavirus
27 January 2020 - - US-based clinical stage biotechnology company Moderna, Inc., (NASDAQ: MRNA) has forged a new collaboration to develop an mRNA vaccine against the novel coronavirus (2019-nCoV), the...
European Clinical Research Centre AP-HP and IQVIA Collaborate to Launch Clinical Investigation Site
27 January 2020 - - European clinical research centre Assistance Publique Hôpitaux de Paris (AP-HP) is joining US-based health technology and human data science company IQVIA to launch the Paris...
Synedgen Granted New EU Patent for Treating GI Mucositis
22 January 2020 - - US-based biotechnology company Synedgen has been awarded a new patent by the European Patent Office, covering aspects of the treatment of mucositis in the gastrointestinal tract wi...
EMA approves Novartis' Mayzent
22 January 2020 - Novartis (SWX: NOVN) a pharmaceutical company reported on Monday that it has been granted a licience for Mayzent (siponimod), the first oral treatment for secondary progressive multi...
Agilent Collaborates with University Researchers Investigating Risk Factors for Eczema
21 January 2020 - - US-based life sciences, diagnostics and applied chemicals company Agilent Technologies Inc. (NYSE: A) is collaborating with researchers at two UK universities who are looking ...
Polaryx Therapeutics wins FDA IND approval for PLX-200 to treat Late Infantile Neuronal Ceroid Lipofuscinosis
21 January 2020 - Biotech company Polaryx Therapeutics revealed on Monday the receipt of US Food and Drug Administration (FDA) Investigational New Drug Application (IND) approval for PLX-200 for the t...